HIGHLIGHTS
- who: Thomas J. Gerton and collaborators from the Division of Women`s and Perinatal Pathology, Department of Pathology, Brigham and Women`s Hospital, Harvard Medical School, Boston, MA, USA have published the paper: Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells, in the Journal: (JOURNAL)
- what: This study shows that epigenetic priming potentiates ICB responses in tumor models and ex vivo 3D patient-derived platforms. The authors report the optimization of a 3D immuno-oncology PDOTS platform for ex vivo screening of HGSOC-derived . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.